And the remarkable alleviation in the cell apoptosis and inflammation after Botch overexpression, suggesting that therapies targeting Notch1 hold significant promise for the treatment and prevention of pathologic processes characterized by ICH-induced brain injury, and Botch might be good target for improving SBI after ICH. The gene discussed is NOTCH1; the disease is injury.